Internal Medicine, Gastroenterology · Summit, NJ
NPI
1649270976
Since 2005
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
0
Medicare group memberships
Hospitals
2
Hospital affiliations
12 Bank St, Suite 102
Summit, NJ, 07901
Phone (908) 273-3434
Medicare paid, 2024
$58K
550 services
Medicare patients, 2024
180
Average age 77
Drug cost, 2024
$418K
713 prescriptions
Company payments, 2025
$385
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Saad F Habba was code 99214 (office e&m - established), 305 times for 133 patients. In total Saad F Habba billed 550 services in 24 codes, and Medicare paid $58K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-03-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 305 | 133 | $96.72 | $29K |
| 43239 Upper GI Endoscopy | Facility | 75 | 65 | $104.70 | $7,853 |
| 99232 Hospital E&M - Subsequent | Facility | 34 | 22 | $57.49 | $1,955 |
| 45380 Lower GI Endoscopy - Other | Facility | 27 | 27 | $128.29 | $3,464 |
| 99205 Office E&M - New | Office | 17 | 17 | $179.91 | $3,059 |
| 45385 Colonoscopy - Lesion Removal | Facility | 16 | 16 | $206.00 | $3,296 |
| 99204 Office E&M - New | Office | 13 | 13 | $96.97 | $1,261 |
| 99215 Office E&M - Established | Office | 12 | 11 | $134.29 | $1,611 |
By year: 2022 $62K for 575 services; 2023 $52K for 485 services; 2024 $58K for 550 services.
Medicare prescription drug claims, 2024
In 2024, the drug Saad F Habba prescribed most often to Medicare patients was Omeprazole, with 140 prescriptions and refills. In total Saad F Habba wrote 713 Medicare prescriptions that cost $418K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 140 | 419 | 51 | $2,308 |
| Colesevelam Hcl Generic | 83 | 228 | 29 | $29K |
| Esomeprazole Magnesium Generic | 63 | 185 | 25 | $2,936 |
| Pantoprazole Sodium Generic | 58 | 155 | 17 | $719 |
| Dexlansoprazole Dr Dexlansoprazole | 37 | 87 | Under 11 | $13K |
| Creon Lipase/Protease/Amylase | 31 | 50 | Under 11 | $126K |
| Sucralfate Generic | 31 | 78 | 19 | $5,065 |
| Colestipol Hcl Generic | 26 | 56 | Under 11 | $4,281 |
| Mesalamine Generic | 24 | 42 | Under 11 | $6,453 |
| Sutab Sod Sulf/Pot Chloride/Mag Sulf | 16 | 16 | 16 | $2,561 |
| Entyvio Vedolizumab | 15 | 22 | Under 11 | $132K |
| Famotidine Generic | 15 | 43 | Under 11 | $174 |
| Nexium Esomeprazole Magnesium | 14 | 20 | Under 11 | $5,159 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 12 | 12 | 11 | $831 |
| Dicyclomine Hcl Generic | 12 | 32 | Under 11 | $141 |
Brand drugs: 150 claims; generic drugs: 563 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Saad F Habba $385 ($385 in general payments such as food, travel and fees) from 5 companies. The largest payer was Abbvie Inc. with $251.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.